Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc. financial statements

Estrella Immunopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

Net income−USD 13.06M10-K
Cash and equivalentsUSD 1.38M10-K

Estrella Immunopharma, Inc. financials on 6ix · Estrella Immunopharma, Inc. on 6ix